<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01173965</url>
  </required_header>
  <id_info>
    <org_study_id>3873</org_study_id>
    <nct_id>NCT01173965</nct_id>
  </id_info>
  <brief_title>Endometrial Ablation With Non-hysteroscopic Methods</brief_title>
  <official_title>Treatment of Dysfunctional Uterine Bleeding With Second Generation Ablation Devices: Microwaves (MEA速) vs Bipolar Impedance Control System (Novasure速)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aristotle University Of Thessaloniki</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endometrial ablation in women with dysfunctional uterine bleeding using second generation
      ablation devices is a common widespread therapeutic approach. This study aims to prove that
      amenorrhoea rates using Novasure are higher than those observed in microwave endometrial
      ablation, one year following intervention.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amenorrhoea rates one year after intervention</measure>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Dysfunctional Uterine Bleeding</condition>
  <arm_group>
    <arm_group_label>Endometrial ablation with microwaves</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endometrial ablation with the use of MEA(microwaves endometrial ablation device)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endometrial ablation with bipolar diathermy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endometrial ablation with Novasure(bipolar impedence control system)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MEA</intervention_name>
    <description>Microwave endometrial ablation device</description>
    <arm_group_label>Endometrial ablation with microwaves</arm_group_label>
    <other_name>Microwaves (MEA速)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Novasure</intervention_name>
    <description>Bipolar impedence control system</description>
    <arm_group_label>Endometrial ablation with bipolar diathermy</arm_group_label>
    <other_name>Bipolar Impedance Control System (Novasure速)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women presenting with dysfunctional uterine bleeding having completed their family
             planning(no wish for further childbearing)

        Exclusion Criteria:

          -  Endometrial pathology

          -  FSH &gt; 20 day 2 -day 3 of the cycle

          -  Clotting Disorders

          -  Thyroid Dysfunction
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>First Dept. Of ObGyn, Medical School Aristotle University of Thessaloniki, Papageorgiou Hospital</name>
      <address>
        <city>Thessaloniki</city>
        <zip>56403</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Dept. of ObGyn, Medical School, Aristotle University of Thessaloniki, Papageorgiou Hospital</name>
      <address>
        <city>Thessaloniki</city>
        <zip>56403</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2010</study_first_submitted>
  <study_first_submitted_qc>August 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2010</study_first_posted>
  <last_update_submitted>July 11, 2012</last_update_submitted>
  <last_update_submitted_qc>July 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 12, 2012</last_update_posted>
  <responsible_party>
    <name_title>George Pados</name_title>
    <organization>1st Dept Of ObGyn, &quot;Papageorgiou&quot; General Hospital, Medical School, Aristotle University of Thessaloniki</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Uterine Hemorrhage</mesh_term>
    <mesh_term>Metrorrhagia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

